Dana Hassouneh | Microbial Cell Biology | Best Researcher Award

Posted on by sciencefather

Dr. Dana Hassouneh | Microbial Cell Biology | Best Researcher Award

Dr. Dana Hassouneh , King Hussein Cancer Center , Jordan

Dana Hassouneh is a dedicated Clinical Pharmacist from Amman, Jordan, with extensive experience working in hospitals, clinics, and community pharmacies. Passionate about patient-centered care, Dana is committed to enhancing medication therapies while continuously expanding her medical knowledge. Dana’s professional expertise includes inpatient pharmacy, chemotherapy, patient counseling, and drug interactions. As a co-investigator in research, she is also deeply involved in improving healthcare outcomes, particularly in oncology. Dana’s strong communication, organizational, and counseling skills have made her a valuable asset in the healthcare field. She is an advocate for educating patients and healthcare professionals to ensure proper medication use and adherence to prescribed therapies.

Publication Profile: 

Orcid

Strengths for the Award πŸ’ͺ

Dana Hassouneh exhibits a strong commitment to patient-centered care and advanced research in the field of clinical pharmacy, particularly in oncology and infectious diseases. Her contributions as a co-investigator in high-impact research, such as the study on microbiological profiles and resistance patterns in pediatric cancer patients, reflect her deep analytical skills and her dedication to improving patient outcomes. Dana’s ability to bridge the gap between clinical practice and research is a standout feature, making her an invaluable asset to the medical community. Her research at the King Hussein Cancer Center, which includes investigating community-acquired pneumonia in cancer patients, demonstrates her ability to approach complex medical problems with a scientific mindset and her willingness to engage in meaningful work to advance healthcare.

Areas for Improvements 🌱

While Dana’s expertise is remarkable, there is always room to expand her research focus and broaden her collaborative network. Increasing her involvement in multi-center, international research collaborations could offer her exposure to a wider variety of data and perspectives, further strengthening her research abilities. Moreover, refining advanced statistical analysis skills and gaining additional training in emerging research methodologies could contribute to more robust and innovative findings. Dana could also consider focusing on improving interdisciplinary collaborations, especially between clinical pharmacy, microbiology, and oncology to enhance her ability to address multifaceted medical challenges.

Education πŸŽ“

Dana graduated from the University of Jordan with a Clinical Pharmacist degree in 2021, achieving an impressive 3.69/4 GPA. Prior to this, she completed her IGCSE studies at Global International School, where she earned a remarkable score of 97.6/100. Throughout her academic journey, Dana has demonstrated exceptional skills in pharmacology and therapeutic practices, laying the foundation for her successful career as a clinical pharmacist. Her education has enabled her to integrate evidence-based medicine into her practice while developing the skills necessary for medication therapy management and patient education. Dana’s academic excellence continues to influence her ongoing professional growth, furthering her ability to contribute to the medical field and improve patient outcomes.

Experience πŸ’Ό

Dana’s career began at Luqman Al-Hakeem Pharmacy, where she gained valuable patient interaction skills while dispensing medications and offering counseling. Later, as a clinical pharmacist at the King Hussein Cancer Center, Dana worked both in inpatient and chemotherapy pharmacies, ensuring safe medication therapy for cancer patients. Her role involved educating healthcare professionals about drug interactions and alternative therapies. Dana’s research experience as a co-investigator has also been significant, analyzing patient outcomes for those with community-acquired pneumonia. She has also trained at various healthcare settings such as Jordan University Hospital and Jordanian Royal Medical Services, enhancing her knowledge of patient medication management and adherence. This diverse experience has honed Dana’s clinical expertise and strengthened her passion for improving patient care and outcomes.

Research Focus πŸ”¬

Dana’s research primarily focuses on improving patient outcomes through medication therapy management and investigating disease-specific therapies. Her recent work as a co-investigator at King Hussein Cancer Center involves studying the characteristics and outcomes of patients with community-acquired pneumonia. Dana is deeply engaged in the process of manuscript writing and data analysis, with a focus on oncology and infectious diseases. She has also contributed to research regarding microbiological profiles and resistance patterns in pediatric cancer patients. Her research aims to provide evidence-based solutions that can enhance treatment protocols, reduce medication errors, and optimize healthcare delivery for cancer patients. Dana’s work contributes to bridging the gap between clinical practice and research, ensuring that patients receive the best possible care based on up-to-date scientific evidence.

Publications Top Notes πŸ“š

Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8‐Year Study at a Comprehensive Cancer Center in Jordan – Cancer Reports (2025-03)

Conclusion 🎯

Dana Hassouneh’s blend of clinical practice and research expertise makes her an excellent candidate for the Research for Best Researcher Award. Her strengths in patient education, counseling, and collaboration with multidisciplinary teams position her as an emerging leader in the field. As she continues to develop her research focus and expands her skill set, Dana is poised to contribute significantly to advancements in clinical pharmacy and oncology research. Her passion, diligence, and commitment to improving patient care are undeniable, making her a valuable asset to the healthcare field.

Hadji Djebar | Microbial Cell Biology | Best Paper Award

Posted on by sciencefather

Prof. Hadji Djebar | Microbial Cell Biology | Best Paper Award

Prof. Hadji Djebar , saida university ,  Algeria

Dr. Djebar Hadji is a professor at Saida University, Algeria, specializing in nonlinear optical (NLO) properties, structural analysis, and theoretical quantum chemistry methods. With a deep passion for material science, his research focuses on the relationship between molecular structure and its photonic and NLO properties. Dr. Hadji has published numerous articles in top-tier scientific journals and is a recognized expert in computational chemistry, particularly within the field of nonlinear optics. His contributions extend to being an editor for BMC Chemistry, Springer, and a referee for several journals in his field. He has demonstrated significant expertise in the theoretical investigation of novel materials, combining both experimental and theoretical approaches. Dr. Hadji is continuously working on advancing the understanding of nonlinear optical properties in various molecular compounds and materials.

Publication Profile: 

Orcid

Strengths for the Award:

Dr. Djebar Hadji’s work is well-regarded in the field of Nonlinear Optical (NLO) properties, with a focus on theoretical quantum chemistry and structure-property relationships. His substantial body of work published in high-impact journals like Journal of Molecular Liquids, Journal of Electronic Materials, and Revue Roumaine de Chimie highlights his expertise in the synthesis, characterization, and theoretical study of NLO materials. Dr. Hadji’s research makes a notable contribution to understanding the photonic behavior and NLO properties of various chemical compounds, from organic to inorganic hybrids. His work on N-acyl glycine derivatives and thiosemicarbazides stands out for their novel approaches and interdisciplinary nature. Theoretical methodologies, alongside experimental validations, provide a well-rounded understanding of the materials under study. Furthermore, his continuous engagement as a reviewer and editor adds to his credibility in the scientific community.

Areas for Improvement:

While Dr. Hadji’s research has covered a broad spectrum of NLO materials, there appears to be room to increase the scope of applications and practical validations of these materials in real-world scenarios. A more applied focus, such as exploring their use in specific devices or industry-related innovations, could be beneficial for the impact and commercial potential of his work. Additionally, expanding collaborative efforts with experimentalists in material fabrication could lead to more direct applications and enhance the relevance of the research.

Education:

Dr. Djebar Hadji completed his academic journey with distinction in the field of chemistry. He earned his Ph.D. in Chemistry from a renowned Algerian institution, focusing on nonlinear optical properties and theoretical quantum chemistry methods. His academic endeavors have led him to explore various facets of computational chemistry, and he has continued to deepen his knowledge and expertise throughout his career. Dr. Hadji’s education has provided him with a robust foundation in both theoretical and experimental aspects of chemistry, which has fueled his research on understanding the complex relationships between molecular structures and their properties. His postgraduate education was complemented by ongoing professional development, where he has continuously engaged with the global scientific community through collaborations, conferences, and publications. This educational background, combined with years of teaching and research experience, has made Dr. Hadji a respected figure in his field.

Experience:

Dr. Djebar Hadji has extensive experience in academia and research. As a professor at Saida University, Dr. Hadji has mentored numerous students, guiding them through the complexities of chemistry and computational modeling. His teaching covers a wide range of topics, including theoretical quantum chemistry and nonlinear optics. Dr. Hadji is actively involved in collaborative research, having contributed to groundbreaking studies published in reputable journals such as Journal of Molecular Liquids, Journal of Electronic Materials, and Physical Chemistry Research. His research spans the theoretical and computational investigation of nonlinear optical properties, focusing on the structure-property relationships in various chemical compounds. Dr. Hadji also holds editorial roles in prominent journals and reviews papers for several renowned scientific publications. His multifaceted experience, including both theoretical and experimental work, positions him as a highly knowledgeable and influential figure in the field of chemistry, particularly in nonlinear optics and material science.

Research Focus:

Dr. Djebar Hadji’s research primarily focuses on nonlinear optical (NLO) properties, the interaction between molecular structures and photonic characteristics, and the application of theoretical quantum chemistry methods. His work investigates how molecular arrangements and electronic properties influence NLO responses, which has vast applications in areas like telecommunications, photonics, and material science. Dr. Hadji’s research explores novel molecular compounds, particularly those with potential for high-performance NLO behavior. He utilizes quantum chemical methods such as DFT (Density Functional Theory) and TD-DFT (Time-Dependent DFT) to predict and analyze molecular properties. Additionally, Dr. Hadji is dedicated to the synthesis and characterization of new materials, including hybrid inorganic-organic systems and azo derivatives. His goal is to design materials with enhanced NLO properties for various technological applications, focusing on optimizing the relationship between structure and function. This research contributes significantly to the development of advanced materials with improved nonlinear optical responses.

Publications Top Notes:

  1. Nonlinear optical and antimicrobial activity of N-acyl glycine derivatives, Journal of Molecular Liquids, 2024 πŸ“–πŸ§¬
  2. Deeper Insights on the Nonlinear Optical Properties of O-acylated Pyrazoles, Journal of Electronic Materials, 2024 πŸ”¬πŸ’‘
  3. Synthesis And Characterization Of Novel Thiosemicarbazide For Nonlinear Optical Applications: Combined Experimental And Theoretical Study, Revue Roumaine de Chimie, 2024 πŸ”¬βš—οΈ
  4. NLO azo compounds with sulfonamide groups: A theoretical investigation, Journal of Indian Chem. Soc., 2023 πŸ§ͺ✨
  5. Synthesis and characterization of novel thiosemicarbazide for nonlinear optical applications, Rev. Roum. Chim., 2023 βš—οΈπŸ”
  6. Efficient NLO Materials Based on Poly(ortho-anisidine) and Polyaniline: A Quantum Chemical Study, Journal of Electronic Materials, 2022 πŸ§¬πŸ’‘
  7. Molecular Structure, Linear, and Nonlinear Optical Properties of Piperazine-1,4-Diium Bis 2,4,6-Trinitrophenolate, Physical Chemistry Research, 2022 βš—οΈπŸ“š
  8. Theoretical insights into the nonlinear optical properties of cyclotriphosphazene, Journal of Materials Science, 2022 πŸ“ŠπŸ”¬
  9. Linear and nonlinear optical properties of anhydride derivatives: A theoretical investigation, December 2021 πŸ§ͺπŸ’‘
  10. Synthesis, spectroscopic characterization, crystal structure, and linear/NLO properties of a new hybrid compound, Journal of Molecular Structure, 2021 πŸ§ͺπŸ”

Conclusion:

Dr. Djebar Hadji’s extensive contribution to the understanding of nonlinear optical properties of various compounds places him as a strong candidate for the Research for Best Paper Award. His solid foundation in both experimental and theoretical aspects of material science and quantum chemistry, as well as his consistent publication record, are commendable. While his work is theoretically rich, adding practical application studies could further enhance his impact and lead to real-world implementation of his discoveries in the field of optics and photonics.